BERWYN, Pa., — AMETEK, Inc. (NYSE: AME) today announced fourth quarter and full year results that established records for orders, sales, operating income, operating margins, net income and diluted earnings per share. AMETEK’s fourth quarter 2012 sales of $841.8 million were up 10% over the same period of 2011. Operating income for the fourth quarter […]
CARLSBAD, Calif., — The board of directors of Life Technologies Corporation has retained Deutsche Bank Securities Inc. and Moelis & Company LLC to assist in its annual strategic review. The board of directors has not decided on any specific course of action. About Life Technologies Life Technologies Corporation (NASDAQ: LIFE) is a global biotechnology company […]
Agilent Technologies Inc. (NYSE: A) today announced that its board of directors has authorized the repurchase of up to $500 million of the company’s common stock during fiscal 2013. The new repurchase authorization replaces Agilent’s existing stock repurchase program, which authorized the repurchase of shares to reduce or eliminate share dilution from equity programs. The […]
PORT WASHINGTON, N.Y., – Pall Corporation (NYSE:PLL) today announced that its board of directors declared a quarterly dividend of 25 cents per share. The dividend is payable on February 22, 2013 to shareholders of record on the close of business on February 8, 2013. The board also increased the company’s authorization to repurchase shares of […]
WATERTOWN, Mass — Dynasil Corporation of America (NASDAQ: DYSL), a leading developer of sensing, detection and analysis technology for homeland security, medical and industrial applications, today announced financial results for fiscal year ended September 30, 2012 and the filing of its Annual Report on Form 10-K within the extension period provided by Rule 12b-25. “We […]
Washington, D.C.,- Danaher Corporation (NYSE:DHR) announced that its President and Chief Executive Officer, H. Lawrence Culp, Jr., will comment tomorrow on the Company’s performance in a presentation at the J.P. Morgan Healthcare Conference in San Francisco, CA. Mr. Culp will communicate that the Company’s fourth quarter 2012 diluted net earnings per share is anticipated to […]
SANTA CLARA, Calif. — Affymetrix, Inc., (NASDAQ: AFFX) today announced that based on preliminary financial data, the Company expects total revenue for the fourth quarter of 2012 will be approximately $84 million, including $18 million from its eBioscience business unit. Excluding eBioscience, the Company’s revenue increased by 1% as compared to the fourth quarter of […]
Sunnyvale, CA –– Labcyte Inc., a privately-held company advancing acoustic liquid handling, today announced it has closed a Series D financing led by the healthymagination fund, a part of GE Ventures. The $5.3 million round also included current Labcyte investors: Abingworth, Alloy Ventures, Cross Atlantic Partners, Delphi Ventures, H&Q Healthcare Investors (NYSE:HQH) and H&Q Life […]
SUNNYVALE, Calif., –Ahead of its presentation at the JP Morgan Healthcare Conference in San Francisco later today, Cepheid (Nasdaq: CPHD) this morning shared an update on Xpert test availability, highlighting that significant progress towards a return to normal manufacturing operations was achieved despite higher than anticipated demand for a number of Xpert test products during […]
Stuttgart, Germany, — The Carl Zeiss Group ended fiscal year 2011/12 (reporting date: 30 Sept. 2012) with a two percent increase in revenue. Revenue totaled EUR 4.163 billion and therefore surpassed the previous year’s figure (prior year*: EUR 4.084 billion). Earnings (EBIT) totaled EUR 420 million (prior year*: EUR 608 million). Particularly strong year-on-year growth […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
